Becton, Dickinson and Company (BDX) Stock

Becton, Dickinson and Company, commonly known as BD, develops, manufactures, and sells a wide array of medical supplies, devices, laboratory equipment, and diagnostic products globally. Serving healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public, BD is renowned for its extensive product portfolio and innovative solutions in healthcare.

The BD Medical segment focuses on providing a range of products including peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, needle-free IV connectors, closed-system drug transfer devices, hypodermic syringes and needles, and anesthesia supplies. It also offers comprehensive IV medication and infusion therapy delivery systems, automated medication dispensing and supply management systems, and medication inventory optimization tools. Additionally, BD Medical addresses the needs of diabetes care with syringes, pen needles, and prefillable drug delivery systems.

BD Life Sciences and BD Interventional are two other critical segments. BD Life Sciences provides specimen and blood collection products, automated blood and tuberculosis culturing systems, molecular testing, microorganism identification, rapid diagnostic assays, and microbiology laboratory automation. It also offers fluorescence-activated cell sorters and analyzers, antibodies, reagent systems, and solutions for single-cell gene expression analysis. The BD Interventional segment offers products for hernia and soft tissue repair, surgical infection prevention, peripheral interventions, and urology and critical care. Founded in 1897, BD is headquartered in Franklin Lakes, New Jersey.